NDC 49281-605

DENGVAXIA

Dengue Tetravalent Vaccine, Live

DENGVAXIA is a Kit in the Vaccine category. It is labeled and distributed by Sanofi Pasteur Inc.. The primary component is .

Product ID49281-605_c1e7a40b-9a3a-4c2a-b91e-b1d97b31514b
NDC49281-605
Product TypeVaccine
Proprietary NameDENGVAXIA
Generic NameDengue Tetravalent Vaccine, Live
Dosage FormKit
Marketing Start Date2019-05-01
Marketing CategoryBLA / BLA
Application NumberBLA125682
Labeler NameSanofi Pasteur Inc.
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 49281-605-01

1 KIT in 1 CARTON (49281-605-01) * .5 mL in 1 VIAL, SINGLE-DOSE (49281-606-58) * .6 mL in 1 VIAL, SINGLE-DOSE (49281-549-58)
Marketing Start Date2019-05-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 49281-605-01 [49281060501]

DENGVAXIA KIT
Marketing CategoryBLA
Application NumberBLA125682
Product TypeVACCINE
Marketing Start Date2019-05-01

Drug Details


Trademark Results [DENGVAXIA]

Mark Image

Registration | Serial
Company
Trademark
Application Date
DENGVAXIA
DENGVAXIA
86633354 4877362 Live/Registered
Sanofi Pasteur
2015-05-18
DENGVAXIA
DENGVAXIA
85499167 4891090 Live/Registered
Sanofi Pasteur
2011-12-19

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.